Holen Sie sich die Stockscreener-App
10.96
3.12%
0.53
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
1.124 | - | - | - |
| Operating Expenses |
22.30%
7.804
|
6.381 | 10.22 | 9.034 | 6.855 |
| Operating Income/Loss |
22.30%
-7.804
|
-6.381 | -10.22 | -9.034 | -6.855 |
| Income/Loss From Continuing Operations Before Tax |
127.76%
-7.42
|
26.73 | -9.955 | -8.896 | -6.753 |
| Income/Loss From Continuing Operations After Tax |
26.36%
-7.42
|
-5.872 | -9.955 | -8.896 | -6.753 |
Net Income/Loss
|
26.36%
-7.42
|
-5.872 | -9.955 | -8.896 | -6.753 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
300.00%
-0.16
|
-0.04 | -0.26 | -0.42 | -0.32 |
| Diluted Earnings Per Share |
300.00%
-0.16
|
-0.04 | -0.26 | -0.42 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
4.74%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):